Search clinical trials for: ALKS 4230
Total 66 results
-
Mural Oncology, IncRecruitingCutaneous Melanoma | Mucosal MelanomaUnited States, Australia, Canada, Italy, Korea, Republic of, Spain, Taiwan, United Kingdom
-
Mural Oncology, IncCompletedAdvanced Solid TumorsCanada, Spain, United States, Australia, Belgium, Korea, Republic of, Poland
-
Mural Oncology, IncCompletedAdvanced Solid TumorsKorea, Republic of, United States, Canada, Netherlands, Spain, Taiwan
-
Mural Oncology, IncImmune Oncology NetworkCompletedNon-cutaneous Squamous Cell Carcinoma of Head and NeckUnited States
-
Seagen Inc.Bristol-Myers SquibbActive, not recruitingHodgkin LymphomaUnited States, Australia, Czechia, Italy, Spain, Poland
-
Mural Oncology, IncRecruitingAdvanced Solid TumorUnited States, Spain
-
Novo Nordisk A/SCompletedNon-alcoholic Fatty Liver DiseaseChina
-
Mural Oncology, IncMerck Sharp & Dohme LLCRecruitingFallopian Tube Cancer | Platinum-resistant Ovarian Cancer | Primary Peritoneal CancerUnited States, Spain, Korea, Republic of, Taiwan, Canada, Israel, France, United Kingdom, Germany, Belgium, Czechia, Singapore, Australia, Austria, Italy
-
TakedaCompletedAdvanced Renal Cell CarcinomaJapan
-
Alkermes, Inc.RecruitingNarcolepsy Type 1United States
-
University of California, San DiegoRecruitingOropharynx CancerUnited States
-
Alkermes, Inc.RecruitingSchizophrenia | Bipolar I DisorderUnited States, Argentina, Mexico, Brazil, Colombia
-
M.D. Anderson Cancer CenterRecruitingRefractory Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Richter Syndrome | Refractory Mantle Cell Lymphoma | Refractory Aggressive B-Cell Non-Hodgkin Lymphoma | Refractory High Grade B-Cell Lymphoma | Refractory Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma | Refractory... and other conditionsUnited States
-
Karolinska InstitutetRecruitingDiabetes Mellitus, Type 2 | Pediatric Obesity | Prediabetic State | Overweight, Childhood | Overnutrition, ChildSweden
-
Alkermes, Inc.Enrolling by invitationSchizophrenia | Bipolar I DisorderUnited States, Argentina, Brazil, Colombia, Mexico
-
Alkermes, Inc.CompletedSchizophrenia | Schizophreniform Disorder | Bipolar I DisorderUnited States, Bulgaria, Russian Federation, Ukraine, Austria, Ireland, Israel, Italy, Korea, Republic of, Poland, United Kingdom, Serbia, Puerto Rico
-
Alkermes, Inc.CompletedBipolar I DisorderUnited States
-
Alkermes, Inc.CompletedFocus of Study is on Healthy Lactating WomenUnited States
-
Alkermes, Inc.CompletedSchizophreniaUnited States
-
Alkermes, Inc.CompletedSchizophrenia | Bipolar I Disorder | Schizophreniform DisordersUnited States, Korea, Republic of, Russian Federation, Ukraine, Austria, Germany, Ireland, Israel, Italy, Poland, Spain, United Kingdom
-
Alkermes, Inc.Terminated
-
BiogenAlkermes, Inc.CompletedMultiple SclerosisUnited States, Bulgaria, Poland, Belgium, Canada, Germany, Russian Federation, Serbia, Spain, Ukraine
-
Alkermes, Inc.CompletedSchizophrenia | Alcohol Use DisorderUnited States, Bulgaria, Poland
-
Alkermes, Inc.Completed
-
Alkermes, Inc.CompletedSchizophreniaUnited States, Puerto Rico
-
Alkermes, Inc.TerminatedRefractory Major Depressive DisorderUnited States, Puerto Rico, Australia
-
Alkermes, Inc.CompletedMajor Depressive DisorderUnited States, Puerto Rico, Australia
-
BiogenAlkermes, Inc.CompletedRelapsing Remitting Multiple SclerosisUnited States, Germany, Poland
-
Alkermes, Inc.CompletedSchizophreniaUnited States, Puerto Rico
-
BiogenCompletedMultiple SclerosisUnited States
-
Alkermes, Inc.CompletedMajor Depressive DisorderUnited States, Australia, Canada
-
Alkermes, Inc.CompletedMajor Depressive DisorderUnited States, Canada, Germany, Puerto Rico
-
Alkermes, Inc.CompletedA Study of Different Titration Schedules of ALKS 5461 in Adults With Major Depressive Disorder (MDD)Major Depressive DisorderUnited States, Canada
-
Alkermes, Inc.CompletedSchizophreniaUnited States, Bulgaria, Ukraine, Serbia
-
Alkermes, Inc.CompletedMajor Depressive DisorderUnited States, Bulgaria
-
Alkermes, Inc.CompletedMajor Depressive DisorderUnited States
-
Alkermes, Inc.CompletedSchizophreniaUnited States, Bulgaria, Korea, Republic of, Malaysia, Philippines, Romania, Russian Federation, Ukraine
-
Alkermes, Inc.CompletedMajor Depressive DisorderUnited States, Canada, Germany, Puerto Rico, Bulgaria, Australia, Poland, Hungary
-
Alkermes, Inc.CompletedSchizophreniaUnited States, Bulgaria, Korea, Republic of, Malaysia, Philippines, Romania, Russian Federation, Ukraine
-
Alkermes, Inc.CompletedSchizophreniaUnited States
-
Alkermes, Inc.Completed
-
Alkermes, Inc.CompletedSchizophreniaUnited States, Bulgaria, Ukraine, Serbia
-
Alkermes, Inc.CompletedSchizophreniaUnited States, Bulgaria, Korea, Republic of, Malaysia, Philippines, Romania, Russian Federation, Ukraine
-
Alkermes, Inc.Completed
-
National Institute on Drug Abuse (NIDA)Alkermes, Inc.CompletedSubstance-Related DisordersUnited States
-
Alkermes, Inc.Completed
-
Alkermes, Inc.CompletedSchizophrenia | Schizoaffective DisorderUnited States
-
Alkermes, Inc.CompletedHepatic ImpairmentUnited States
-
Alkermes, Inc.CompletedPharmacokinetics and Safety of ALKS 5461 in Subjects With Renal Impairment and Normal Renal FunctionRenal ImpairmentUnited States
-
Alkermes, Inc.CompletedHealthyUnited States